IRAK1 and diabetes mellitus: Well-documented evidence demonstrates that IRAK1 is one of the central kinases involved in the development of various diseases, such as cancer, metabolic disorders (e.g., diabetes), infection (e.g., sepsis), and non-infectious immune diseases (e.g., systemic lupus erythematous) [17].